PLATINUM Workhorse Trial

Study Objective

Evaluate the safety and effectiveness of the PROMUS Element™ Stent System for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25mm in diameter compared to the Xience V™ Stent System

Study Design

Prospective, Randomized, Controlled, Non-inferiority, Multicenter

Platform Influences Outcomes

The PLATINUM Workhorse Trial 4-Year data reinforce the influence that Platinum Chromium (PtCr) stent alloy has on outcomes.

Numerically Lower Ischemia-Driven TLR through 4 Years1

4-Year Results

Numerically Lower Ischemia-Driven TLR through 4 Years Numerically Lower Ischemia-Driven TLR through 4 Years

Numerically Lower Event Rates1

4-Year Clinical Results

PLATINUM Workhorse Clinical Trial Numerically Lower Event Rates 4 Year Results PLATINUM Workhorse Clinical Trial Numerically Lower Event Rates 4 Year Results

Significant Reduction In Unplanned Bail-out Stenting = $116 Savings / Procedure2, 3

1-Year Results

Top